The COVID-19 vaccine has prompted more than 10 times as many reports of adverse symptoms than the measles vaccine.

Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi ...

House Republicans are urging President Trump to use executive action on COVID-19 mandates for organ transplants.

Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

A bill banning gene-based vaccines, like some forms of the COVID-19 vaccine, received approval from a Senate subcommittee ...

Cornell University researchers used a new technology to design a vaccine that they say provides full protection against both ...

Yale researchers have found clues as to why certain people experience adverse health effects after the COVID-19 vaccine, ...

The new vaccine addresses significant limitations of existing COVID-19 and flu vaccines. While mRNA COVID-19 vaccines require ...

The current COVID-19 vaccine is 33% effective at preventing emergency department or urgent care visits among adults of all ages. It also is 45% to 46% effective at preventing hospitalizations in older ...

In a small study, Yale researchers have found "differences in immune profiles" among those who have rare reaction to the ...

Few Minnesotans sought the COVID-19 vaccine to reduce their infection risks this winter, but at least the shots offered some ...